MICHELE CARBONE , MD , PHD
( 2009-2014 )
|
RANDALL F . HOLCOMBE , MD , MBA
( 2016-2021 )
|
|||||
DR . CARBONE ’ S legacy is teamwork , achievements , and seminal discoveries in cancer research . He secured the renewal of the NCI core grant in 2012 . He led the establishment of the Hawai ‘ i Cancer Consortium to give cancer patients in Hawai ‘ i access to clinical trials via the UH Cancer Center . Dr . Carbone worked with the local firm Kobayashi Group ' s architect Jeff Nakamura to design and build a modern research facility in Kaka ‘ ako with open spaces , resulting in one of the most beautiful cancer centers in the U . S . He was able to recruit 24 top-notch new faculty members and reorganized administration to work with consortium members . During his directorship , the UH |
Cancer Center renewed its NCI designation , tripled its NCI funding , rallied the community behind the Cancer Center , and raised over $ 30M in philanthropic funds . At the same time , Dr . Carbone and his collaborators discovered the “ BAP1 cancer syndrome ”, a discovery that is not only helping save lives but has become the model to study gene x environment interaction in cancer . |
DR . HOLCOMBE ’ S greatest impact as UH Cancer Center Director was to renew and strengthen the focus of all of the Cancer Center ’ s research on the people of Hawai ‘ i and the U . S . -affiliated Pacific Islands , including population sciences , cancer epidemiology , basic cancer biology , clinical and disease-focused research , and cancer prevention . This renewed focus , addressing the cancer burden and cancer outcome disparities among unique populations , led to innumerable successes , including the renewal of the Cancer Center Support Grant in 2018 ; renewal and addition of new members to the Hawai ‘ i Cancer Consortium ; renewal of the NCORP clinical trials grant , for which he served as multiple-principal investigator ( MPI ), with expansion of the Cancer Center clinical research network across Hawai ‘ i |
and Guam ; renewal of the Pacific Island Partnership for Cancer Health Equity grant , for which he also served as MPI ; and securing State and National Institutes of Health ( NIH ) funding to establish an early phase clinical research center to serve the people of Hawai ‘ i and the Pacific . These successes , along with high impact research relevant to Hawai ‘ i and the Pacific conducted by a dedicated and enthusiastic faculty and staff , has put the UH Cancer Center on a sound foundation to enable ongoing , future success . |